시장보고서
상품코드
1087332

세계의 유방암 액체생검 검사기기 시장(2022-2026년)

Global Breast Cancer Liquid Biopsy Testing Devices Market 2022-2026

발행일: | 리서치사: TechNavio (Infiniti Research Ltd.) | 페이지 정보: 영문 120 Pages | 배송안내 : 즉시배송

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 유방암 액체생검 검사기기 시장 규모는 2022-2026년간 7억 3,040만 달러 확대될 전망이며, 예측 기간에 23.58%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예측됩니다.

유방암 유병률 상승, 비침습적 치료법 선호, 신제품 발매 및 FDA 승인 증가가 시장 성장의 원동력이 되고 있습니다.

세계의 유방암 액체생검 검사기기(Breast Cancer Liquid Biopsy Testing Device) 시장에 대해 조사분석했으며, 전체적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제 및 약 25개 벤더를 분석한 정보를 제공합니다.

목차

제1장 개요

  • 시장 개요

제2장 시장 구도

  • 시장 생태계

제3장 시장 규모

  • 시장의 정의
  • 시장 부문 분석
  • 시장 규모(2021년)
  • 시장 전망 : 예측(2021-2026년)

제4장 Five Forces 분석

  • Five Forces 요약
  • 바이어의 교섭력
  • 공급 기업의 교섭력
  • 신규 진출업체의 위협
  • 대체품의 위협
  • 경쟁사의 위협
  • 시장 현황

제5장 유형별 시장 세분화

  • 시장 부문
  • 유형별 비교
  • CTC/순환 핵산(circulating nucleic acids) : 시장 규모와 예측(2021-2026년)
  • 세포외소포 : 시장 규모와 예측(2021-2026년)
  • 유형별 시장 기회

제6장 고객 상황

  • 고객 상황 개요

제7장 지역별 상황

  • 지역별 세분화
  • 지역별 비교
  • 북미 : 시장 규모와 예측(2021-2026년)
  • 유럽 : 시장 규모와 예측(2021-2026년)
  • 아시아 : 시장 규모와 예측(2021-2026년)
  • 기타 지역(ROW) : 시장 규모와 예측(2021-2026년)
  • 미국 : 시장 규모와 예측(2021-2026년)
  • 독일 : 시장 규모와 예측(2021-2026년)
  • 캐나다 : 시장 규모와 예측(2021-2026년)
  • 중국 : 시장 규모와 예측(2021-2026년)
  • 프랑스 : 시장 규모와 예측(2021-2026년)
  • 영국 : 시장 규모와 예측(2021-2026년)
  • 지역 상황별 시장 기회

제8장 시장 성장 촉진요인, 과제 및 동향

  • 시장 성장 촉진요인
  • 시장이 해결해야 할 과제
  • 시장 성장 촉진요인과 과제의 영향
  • 시장 동향

제9장 벤더 구도

  • 개요
  • 벤더 구도
  • 혼란 상황
  • 업계 리스크

제10장 벤더 분석

  • 대상 벤더
  • 벤더의 시장 포지셔닝
  • A. Menarini Industrie Farmaceutiche Riunite Srl
  • Exact Sciences Corp.
  • F. Hoffmann La Roche Ltd.
  • Illumina Inc.
  • Isogen Life Science BV
  • Myriad Genetics Inc.
  • Natera Inc.
  • Novogene Corp.
  • QIAGEN NV
  • Thermo Fisher Scientific Inc.

제11장 부록

LSH 22.06.15

Technavio has been monitoring the breast cancer liquid biopsy testing devices market and it is poised to grow by $ 730.4 mn during 2022-2026, accelerating at a CAGR of 23.58% during the forecast period. Our report on the breast cancer liquid biopsy testing devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of breast cancer, increasing preference for non-invasive procedures, and rising number of new product launches and FDA approvals.

The breast cancer liquid biopsy testing devices market analysis includes the type segment and geographic landscape.

Technavio's breast cancer liquid biopsy testing devices market is segmented as below:

By Type

  • CTCs and circulating nucleic acids
  • Extracellular vesicles

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the technological advances as one of the prime reasons driving the breast cancer liquid biopsy testing devices market growth during the next few years. Also, growing emphasis on breast cancer diagnosis and increasing focus on direct-to-customer marketing will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on breast cancer liquid biopsy testing devices market covers the following areas:

  • Breast cancer liquid biopsy testing devices market sizing
  • Breast cancer liquid biopsy testing devices market forecast
  • Breast cancer liquid biopsy testing devices market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading breast cancer liquid biopsy testing devices market vendors that include A. Menarini Industrie Farmaceutiche Riunite Srl, Agena Bioscience Inc., Bio Rad Laboratories Inc., Exact Sciences Corp., F. Hoffmann La Roche Ltd., Fluxion Biosciences Inc., Guardant Health Inc., Illumina Inc., Isogen Life Science BV, Myriad Genetics Inc., Natera Inc., NeoGenomics Laboratories Inc., Novogene Corp., OncoDNA SA, Pfizer Inc., QIAGEN NV, SAGA Diagnostics AB, Sysmex Corp., and Thermo Fisher Scientific Inc. Also, the breast cancer liquid biopsy testing devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Type

  • 5.1 Market segments
  • Exhibit 24: Chart on Type - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
  • 5.2 Comparison by Type
  • Exhibit 26: Chart on Comparison by Type
  • Exhibit 27: Data Table on Comparison by Type
  • 5.3 CTCs and circulating nucleic acids - Market size and forecast 2021-2026
  • Exhibit 28: Chart on CTCs and circulating nucleic acids - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on CTCs and circulating nucleic acids - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on CTCs and circulating nucleic acids - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on CTCs and circulating nucleic acids - Year-over-year growth 2021-2026 (%)
  • 5.4 Extracellular vesicles - Market size and forecast 2021-2026
  • Exhibit 32: Chart on Extracellular vesicles - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on Extracellular vesicles - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on Extracellular vesicles - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on Extracellular vesicles - Year-over-year growth 2021-2026 (%)
  • 5.5 Market opportunity by Type
  • Exhibit 36: Market opportunity by Type ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 40: Chart on Geographic comparison
  • Exhibit 41: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 Germany - Market size and forecast 2021-2026
  • Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.9 Canada - Market size and forecast 2021-2026
  • Exhibit 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 7.10 China - Market size and forecast 2021-2026
  • Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
  • 7.11 France - Market size and forecast 2021-2026
  • Exhibit 74: Chart on France - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on France - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on France - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on France - Year-over-year growth 2021-2026 (%)
  • 7.12 UK - Market size and forecast 2021-2026
  • Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • 7.13 Market opportunity By Geographical Landscape
  • Exhibit 82: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 83: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 85: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 86: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 87: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 88: Matrix on vendor position and classification
  • 10.3 A. Menarini Industrie Farmaceutiche Riunite Srl
  • Exhibit 89: A. Menarini Industrie Farmaceutiche Riunite Srl - Overview
  • Exhibit 90: A. Menarini Industrie Farmaceutiche Riunite Srl - Product / Service
  • Exhibit 91: A. Menarini Industrie Farmaceutiche Riunite Srl - Key offerings
  • 10.4 Exact Sciences Corp.
  • Exhibit 92: Exact Sciences Corp. - Overview
  • Exhibit 93: Exact Sciences Corp. - Product / Service
  • Exhibit 94: Exact Sciences Corp. - Key offerings
  • 10.5 F. Hoffmann La Roche Ltd.
  • Exhibit 95: F. Hoffmann La Roche Ltd. - Overview
  • Exhibit 96: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibit 97: F. Hoffmann La Roche Ltd. - Key news
  • Exhibit 98: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibit 99: F. Hoffmann La Roche Ltd. - Segment focus
  • 10.6 Illumina Inc.
  • Exhibit 100: Illumina Inc. - Overview
  • Exhibit 101: Illumina Inc. - Business segments
  • Exhibit 102: Illumina Inc. - Key news
  • Exhibit 103: Illumina Inc. - Key offerings
  • Exhibit 104: Illumina Inc. - Segment focus
  • 10.7 Isogen Life Science BV
  • Exhibit 105: Isogen Life Science BV - Overview
  • Exhibit 106: Isogen Life Science BV - Product / Service
  • Exhibit 107: Isogen Life Science BV - Key offerings
  • 10.8 Myriad Genetics Inc.
  • Exhibit 108: Myriad Genetics Inc. - Overview
  • Exhibit 109: Myriad Genetics Inc. - Product / Service
  • Exhibit 110: Myriad Genetics Inc. - Key offerings
  • 10.9 Natera Inc.
  • Exhibit 111: Natera Inc. - Overview
  • Exhibit 112: Natera Inc. - Product / Service
  • Exhibit 113: Natera Inc. - Key offerings
  • 10.10 Novogene Corp.
  • Exhibit 114: Novogene Corp. - Overview
  • Exhibit 115: Novogene Corp. - Product / Service
  • Exhibit 116: Novogene Corp. - Key offerings
  • 10.11 QIAGEN NV
  • Exhibit 117: QIAGEN NV - Overview
  • Exhibit 118: QIAGEN NV - Product / Service
  • Exhibit 119: QIAGEN NV - Key news
  • Exhibit 120: QIAGEN NV - Key offerings
  • 10.12 Thermo Fisher Scientific Inc.
  • Exhibit 121: Thermo Fisher Scientific Inc. - Overview
  • Exhibit 122: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 123: Thermo Fisher Scientific Inc. - Key news
  • Exhibit 124: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 125: Thermo Fisher Scientific Inc. - Segment focus

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 126: Inclusions checklist
  • Exhibit 127: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 128: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 129: Research methodology
  • Exhibit 130: Validation techniques employed for market sizing
  • Exhibit 131: Information sources
  • 11.5 List of abbreviations
  • Exhibit 132: List of abbreviations
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제